PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis

PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis

Background Despite a series of attempts during the last decades, the prognosis for esophageal squamous cell carcinoma (ESCC) remains poor. Although clinical immunotherapy trials have shown encouraging results, their benefits are limited. This study aims to identify novel targets for immunotherapy in...

Full description

Saved in:
Bibliographic Details
Main Authors: Ning Ma, Wei Chen, Yu Chen, Xiang Wang, Bing Zhu, Kai Ding, Lin Qiu, Jing-jing Li, Jing-Yi Huang, Xin Liang, Yan-Jun Xiang, Qian-Zhi Ni, Zhi-Chao Liu, Qian-Wen Zheng, Yi-Kang Wang, Hui-Jun Cao, Ji Xia, Sheng Xu, Xiao-Song Qiu, Xi-Ran Zhang, Lingyun Long, Zhi-Gang Li, Fan Yao
Format: Article
Language:English
Published: BMJ Publishing Group 2025-08-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/8/e012044.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jitc.bmj.com/content/13/8/e012044.full

Similar Items